CDKN2A and astrocytoma (excluding glioblastoma): According to the recent change of IDH-mutant astrocytoma grading in the 2021 WHO Classification of CNS tumors, tumors containing CDKN2A/B HD are accepted as grade 4 even if they do not contain MVP and/or necrosis (1).